As shown in Table 1, a positive SKP2 expression was significantly associated with smaller tumor size, lower T category, lower N category, lower stage group, lower recurrence rate, less lymphatic invasion, and less vascular invasion. The gene discussed is SKP2; the disease is neoplasm.